(Q53090551)

English

The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase. (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

author name string

Chung-Chia Liao

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

Ting-Tsz Ou

2

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

Hui-Pei Huang

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

Chau-Jong Wang

4

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

language of work or name

0 references

publication date

10 October 2013

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

Journal of the Science of Food and Agriculture

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

94

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

6

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

1154-1162

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Current therapeutic strategies in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Metformin reverses fatty liver disease in obese, leptin-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Dietary fat content modifies liver fat in overweight nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Structure-antioxidant activity relationships of flavonoids and phenolic acids

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Caffeic acid alleviates the increased lipid levels of serum and tissues in alcohol-induced [hepatotoxicity in] rats

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Protective effects of caffeic acid phenethyl ester on iron-induced liver damage in rats

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

The effect of caffeic acid phenethyl ester (CAPE) against cholestatic liver injury in rats

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Nile red: a selective fluorescent stain for intracellular lipid droplets

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Pathogenesis of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Peroxisome proliferator-activated receptor alpha target genes.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Polyunsaturated fatty acids decrease the expression of sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol transport

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Liver fatty acid binding protein expression enhances branched-chain fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats

1 reference

https://api.crossref.org/works/10.1002%2FJSFA.6386

21 January 2018

Identifiers

10.1002/JSFA.6386

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/24027117

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53090551&oldid=912179285"